arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Genpact Limited

G Consumer Discretionary Professional Services
$40.90
▲ +4.0% Today
as of Oct 23, 14:32 ET
Last 30 days +12.08% Sep 14 → Oct 23
$31.48 $34.24 $37.01 $39.78 $42.54 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$39.80
High
$41.91
Low
$39.72
Volume
$3M
Avg Vol
$2M
Mkt Cap
$5.6B
P/E (TTM)
14.61
Beta
—
52w High
$48.64
52w Low
$26.85
Div Yield
—
Shares Out
$168M

Recent Press Releases & News last 60 days · 24 items

Oct 22 · 20:11 Simply Wall St.
Genpact (G) Stock Still Looks Cheap Despite Its 24% Run
Oct 19 · 15:10 Zacks
Will Genpact (G) Beat Estimates Again in Its Next Earnings Report?
Oct 19 · 12:05 PR PR Newswire
Genpact Awarded Everest Group's 2026 Elevate Honors for Market-Leading Growth
▸ Show all 24 press releases & news Free account →

G earnings at a glance

Genpact Limited (G) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Analysts expect earnings per share of $0.93, compared with $0.87 in the same quarter last year (+7%). The options market is pricing a move of about ±3.8% after the report, a range of roughly $39.37 to $42.43 from today's $40.90. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±8.9% on average; after the most recent report on Aug 6, 2026 it moved -5.2%. That means options currently expect less movement than G has typically delivered. G beat the consensus EPS estimate in 5 of its last 6 reported quarters. Implied volatility is currently 32%. The share price of $40.90 sits in the middle of its 52-week range.

More Consumer Discretionary stocks · All stocks · Earnings calendar

Overview

52-week range
$27
$49
64% of range
Avg surprise (last 6)
+3.1%
Avg reaction (last 6)
+0.2%
50% positive
Latest IV / EM
32%
EM ±3.8% · $35 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.57$0.65$0.73$0.81$0.89 Actual $0.57Actual $0.63Actual $0.64Actual $0.64Actual $0.67Actual $0.74Actual $0.73Est $0.72Actual $0.76Est $0.75Actual $0.87Est $0.79Actual $0.82Est $0.83Actual $0.85Est $0.83Actual $0.89Est $0.85 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$0$353M$705M$1.1B$1.4B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Aug 6, 2026Jun/2026 $0.89 $0.85 +4.7% +11.8% -5.2% earnings
Thu May 7, 2026Mar/2026 $0.85 $0.83 +2.4% +16.4% -5.6% earnings
Thu Feb 5, 20268K 2026-02-05 $0.82 $0.83 -1.2% — +7.1% earnings
Thu Nov 6, 2025Sep/2025 $0.87 $0.79 +10.1% — +15.9% earnings
Thu Aug 7, 2025Jun/2025 $0.76 $0.75 +1.3% — +4.4% earnings
Wed May 7, 2025Mar/2025 $0.73 $0.72 +1.4% — -15.2% earnings
Mon Sep 30, 2024Sep 2024 $0.74 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.67 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.64 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.64 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.63 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.57 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Nov 5, 2026Sep/2026OTHER $0.93$0.87 +6.9%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.34B$1.30B—$1.29B$1.25B$1.21B—$1.21B
Cost of revenue$853M$824M—$822M$804M$786M—$780M
Gross profit$490M$472M—$470M$450M$429M—$431M
Operating income$193M$199M—$192M$179M$184M—$182M
Net income$146M$148M—$146M$133M$131M—$133M
EPS (diluted)$0.86$0.86—$0.83$0.75$0.73—$0.74

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$517M$578M$854M$741M$663M$562M$648M$1.02B
Inventory————————
Total current assets$2.17B$2.41B$2.66B$2.21B$2.14B$1.94B$2.08B$2.40B
Total assets$5.41B$5.62B$5.84B$5.36B$5.31B$4.89B$4.99B$5.33B
Long-term debt$1.15B$1.16B$1.17B$827M$833M$1.19B$1.20B$1.20B
Total liabilities$2.81B$3.14B$3.29B$2.82B$2.72B$2.44B$2.60B$2.93B
Total equity$2.60B$2.48B$2.55B$2.54B$2.59B$2.45B$2.39B$2.39B

Implied volatility — last 90 days

22%83%144%204%265% Jun 07 — IV 72% · EM ±10.0%Jun 08 — IV 125% · EM ±16.6%Jun 09 — IV 76% · EM ±9.5%Jun 10 — IV 134% · EM ±15.8%Jun 11 — IV 85% · EM ±9.4%Jun 12 — IV 145% · EM ±14.8%Jun 15 — IV 75% · EM ±5.4%Jun 16 — IV 183% · EM ±10.8%Jun 19 — IV 50% · EM ±11.1%Jun 22 — IV 46% · EM ±9.5%Jun 23 — IV 42% · EM ±8.6%Jun 24 — IV 72% · EM ±14.4%Jun 25 — IV 81% · EM ±15.9%Jun 26 — IV 47% · EM ±8.9%Jun 29 — IV 57% · EM ±10.1%Jun 30 — IV 67% · EM ±11.5%Jul 01 — IV 58% · EM ±9.6%Jul 02 — IV 52% · EM ±8.3%Jul 03 — IV 53% · EM ±8.3%Jul 06 — IV 55% · EM ±7.6%Jul 07 — IV 48% · EM ±6.3%Jul 08 — IV 48% · EM ±6.0%Jul 09 — IV 48% · EM ±5.7%Jul 10 — IV 47% · EM ±5.2%Jul 13 — IV 66% · EM ±5.5%Jul 14 — IV 122% · EM ±8.8%Jul 15 — IV 117% · EM ±6.9%Jul 16 — IV 132% · EM ±5.5%Jul 20 — IV 57% · EM ±13.4%Jul 21 — IV 54% · EM ±12.6%Jul 22 — IV 55% · EM ±12.7%Jul 23 — IV 49% · EM ±11.0%Jul 24 — IV 55% · EM ±12.1%Jul 27 — IV 68% · EM ±14.1%Jul 28 — IV 56% · EM ±11.4%Jul 29 — IV 87% · EM ±17.4%Jul 30 — IV 67% · EM ±13.2%Jul 31 — IV 52% · EM ±10.0%Aug 03 — IV 62% · EM ±10.9%Aug 04 — IV 62% · EM ±10.6%Aug 05 — IV 58% · EM ±9.6%Aug 06 — IV 88% · EM ±14.3%Aug 07 — IV 54% · EM ±8.5%Aug 10 — IV 51% · EM ±7.1%Aug 11 — IV 46% · EM ±6.1%Aug 12 — IV 47% · EM ±5.9%Aug 13 — IV 22% · EM ±2.6%Aug 14 — IV 45% · EM ±4.9%Aug 17 — IV 64% · EM ±5.3%Aug 18 — IV 50% · EM ±3.6%Aug 19 — IV 140% · EM ±8.2%Aug 20 — IV 266% · EM ±11.1%Aug 24 — IV 45% · EM ±9.3%Aug 25 — IV 41% · EM ±8.4%Aug 26 — IV 49% · EM ±9.8%Aug 27 — IV 46% · EM ±9.1%Aug 28 — IV 46% · EM ±8.9%Aug 31 — IV 45% · EM ±7.9%Sep 01 — IV 40% · EM ±6.8%Sep 02 — IV 52% · EM ±8.8%Sep 03 — IV 50% · EM ±8.0%Sep 04 — IV 48% · EM ±7.6%Sep 07 — IV 55% · EM ±7.6%Sep 08 — IV 40% · EM ±5.3%Sep 09 — IV 35% · EM ±4.4%Sep 10 — IV 47% · EM ±5.6%Sep 11 — IV 32% · EM ±3.6%Sep 14 — IV 67% · EM ±5.6%Sep 15 — IV 72% · EM ±5.2%Sep 16 — IV 41% · EM ±2.4%Sep 17 — IV 70% · EM ±2.9%Sep 21 — IV 36% · EM ±7.6%Sep 22 — IV 37% · EM ±7.6%Sep 23 — IV 41% · EM ±8.1%Sep 24 — IV 34% · EM ±6.7%Sep 25 — IV 38% · EM ±7.3%Sep 28 — IV 52% · EM ±9.3%Sep 29 — IV 49% · EM ±8.5%Sep 30 — IV 51% · EM ±8.5%Oct 01 — IV 33% · EM ±5.3%Oct 02 — IV 54% · EM ±8.4%Oct 06 — IV 45% · EM ±5.9%Oct 07 — IV 46% · EM ±5.8%Oct 08 — IV 32% · EM ±3.8%

Sector peers

FCN
FTI Consulting, Inc.
$3.8B $156.78+5.0%
RHI
Robert Half Inc.
$3.5B $46.45+34.1%
EXPO
Exponent, Inc.
$3.3B $77.49+5.9%
BAH
Booz Allen Hamilton Holding Corporation
$8.3B $77.86+3.8%
HURN
Huron Consulting Group Inc.
$2.5B $195.43+6.6%
MAN
ManpowerGroup
$2.5B $48.38+8.4%

G earnings FAQ

When is G's next earnings date?

Genpact Limited is expected to report on November 5, 2026.

What is G's expected move for earnings?

Options currently price a move of about ±3.8%, or $1.53 per share either way from $40.90.

How does G stock usually react to earnings?

Across the last 6 reports the average next-day move was ±8.9%, up 3 times and down 3 times.

What EPS are analysts expecting from Genpact Limited?

The consensus estimate is $0.93 per share, versus $0.87 a year ago.

What is G's implied volatility?

G's at-the-money implied volatility is about 32% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in